Back Stocks profile

Stock analysis tool for investors

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE:500124

₹5958.00 7.20 (0.12%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

5928.00

Today’s High

5980.00

52W low

4384.00

52W High

6505.90

Open Price

5975.00

Prev. Close

5467.75

Volume

25209.00

Value

150195222.00

Fundamentals

Market Cap Cr

99387.30

Price to Earnings

19.00

Price to Book Value

4.30

Dividend Yield

0.70

PE to Growth

0.40

Op Revenue TTM Cr

27212.50

Net Profit TTM Cr

5228.20

Cash From Operating Activity Cr

5887.50

Return on Equity %

19.35

EMA & SMA

Bullish Moving Averages

3

Bearish Moving Averages

13

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

24 Apr, 2024

58.1

Week

58.2

Month

52.9

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

5955.57

PIVOT

First Resistance

5990.08

Second Resistance

6029.37

Third Resistance

6063.88

First Support

5916.28

Second Support

5881.77

Third Support

5842.48

Relative Strength Index

38.26

Money Flow Index

30.01

MACD

-67.7

MACD Signal

-50.3

Average True Range

116.99

Average Directional Index

12.13

Rate of Change (21)

-2.5

Rate of Change (125)

6.85

Commodity Channel Index

-123

Williams %R

-83.5

BETA

1 Month

1

3 Month

0.37

1 Year

0.3

3 Year

0

PRICE CHANGE ANALYSIS

-1.53%

1 Week

Low

High

5880.8

6127.5

-3.95%

1 Month

Low

High

5880.8

6305.85

0.95%

3 Months

Low

High

5740.2

6505.9

7.31%

6 Months

Low

High

5205.55

6505.9

23.97%

1 Year

Low

High

4384.05

6505.9

Bigul
24 Apr 2024

Dr. Reddy's Laboratories recalls sapropterin dihydrochloride oral solution powder

Dr Reddy's Laboratories recalls oral solution powder over fears of reduced potency, associated health risks
23 Apr 2024

Dr Reddy's Recalls Six Lots Of Drug In US Due To Subpotency

The issue was discovered during an accelerated stability test in addition to customer complaints.
Bigul
20 Apr 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Bigul
19 Apr 2024

Dr Reddy's rolls out condition management programme for irritable bowel syndrome

IBS is a functional gastrointestinal disorder characterised by abdominal pain, bloating and altered bowel habits
Bigul
19 Apr 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024

Certiifcate under Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2024
Bigul
18 Apr 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
See all News

FAQs

The latest market price of Dr. Reddy's Laboratories Ltd. on NSE was Rs. 5958.00 as of today.

The opening share price of Dr. Reddy's Laboratories Ltd. was Rs. 5975.00 as of today.

The 52-week high share price of Dr. Reddy's Laboratories Ltd. was Rs. 6505.90.

The 52 week low share price of Dr. Reddy's Laboratories Ltd. was Rs. 4384.00.

Dr. Reddy's Laboratories Ltd. has a market cap of Rs. 99387.30 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Dr. Reddy's Laboratories Ltd. is 0.40. Please refer to the Fundamentals section for further details.

The operating revenue for Dr. Reddy's Laboratories Ltd. in the last FY was Rs.  27212.50 crore. Please refer to the Financials section for further details.

The Net Profit for Dr. Reddy's Laboratories Ltd. in the last FY was Rs. 5228.20 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Dr. Reddy's Laboratories Ltd. was on 2023-07-11 for Rs. 40 per share. According to today’s share price, the dividend yield of Dr. Reddy's Laboratories Ltd. stands at 0.70. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Dr. Reddy's Laboratories Ltd. was as of 2006-08-28. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Dr. Reddy's Laboratories Ltd. was as of 2001-10-10. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Dr. Reddy's Laboratories Ltd..

Open Account

Let's Open Free Demat Account

Close

Let's Open Free Demat Account